+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanotechnology in Medical Applications: The Global Market

  • ID: 4410523
  • Report
  • March 2022
  • Region: Global
  • 100 Pages
  • BCC Research
This report examines the current and forecast market potential for nanomedicine. It offers a detailed analysis of the market background, technological advancements, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for nanomedicine based on therapeutic areas and geography. By therapeutic area, the nanomedicine market is segmented into anticancer, CNS products, anti-infectives, anti-inflammatories, cardiovascular, and others. By geography, the nanomedicine market has been segmented into Europe, North America, Asia-Pacific (APAC), and the Rest of the Word (ROW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are included in the regional segments. For market estimates, data is provided for 2020 as the base year, 2021 and forecast through year-end 2026. Estimated values used are based on nanomedicine companies’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.



Report Includes


  • 24 tables
  • An overview of the global markets for nanotechnology used in medical applications
  • Estimation of the market size, and analyses of the global market trends with data from 2019, 2020, 2021, with projection of CAGR through 2026
  • A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications
  • Information on significant products in which the nano dimension has made a significant contribution to product effectiveness
  • A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine
  • Identification of key market dynamics, trends, opportunities, and factors influencing the global market and highlights of the market potential for nanotechnology used in medical applications based on type, application, and region
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players in the market, including Abbott, Abraxis Bioscience, Elan, Orthovita Inc., EyePoint Pharmaceuticals Inc. and Farfield Scientific Ltd
Frequently Asked Questions about the Nanotechnology in Medical Applications Market

What is the estimated value of the Nanotechnology in Medical Applications Market?

The Nanotechnology in Medical Applications Market was estimated to be valued at $242.6 Billion in 2021.

What is the growth rate of the Nanotechnology in Medical Applications Market?

The growth rate of the Nanotechnology in Medical Applications Market is 15.3%, with an estimated value of $493.5 Billion by 2026.

What is the forecasted size of the Nanotechnology in Medical Applications Market?

The Nanotechnology in Medical Applications Market is estimated to be worth $493.5 Billion by 2026.

Who are the key companies in the Nanotechnology in Medical Applications Market?

Key companies in the Nanotechnology in Medical Applications Market include Abbott, Abraxis Bioscience (Celgene {Bristol Myers Squibb}), Aphios Corp., Bioforce Nanosciences Holdings Inc., C Sixty Inc. (Arrowhead Pharmaceuticals), Elan (Alkermes), Eyepoint Pharmaceuticals Inc. (Formerly Psivida Ltd.), Farfield Scientific (Biolin Scientific Ab) and Liplasome Pharma Aps.

Table of Contents

Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing this Study
  • What's New in this Report
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Publisher Custom Research
  • Related Bcc Research Reports

Chapter 2 Summary and Highlights
  • Highlights of the Market for Nanomedicine

Chapter 3 Market Overview
  • Definition
  • Applications
  • Drug Delivery
  • Drugs and Therapy
  • in Vivo Imaging
  • in Vitro Diagnostics
  • Biomaterials
  • Active Implants
  • Overview
  • Medical Nanotechnology: Nanomedicine
  • Nanotechnology
  • Nanotechnology Uses
  • Medical Applications
  • Environmental Applications
  • Military Applications
  • Cosmetics
  • Nanotechnology Tools
  • Risks of Nanotechnology
  • Nanotechnology in the Marketplace
  • Development of Nanomedical Technologies
  • Liposomes
  • Dendrimers
  • Nanocrystals
  • Micelles
  • Fullerenes
  • Polymeric Nanoparticles
  • Nanoparticle-Drug Conjugates
  • Ligand-Targeted Nanoparticles
  • Ceramic Nanoparticles
  • Virosome Nanoparticles
  • Therapeutic Uses of Nanomedicine
  • Cancer Diagnostics and Therapy
  • Drug Delivery
  • Future Trends and Research Possibilities
  • Non-Invasive Nanodevices
  • Extracellular Devices
  • Intracellular Devices
  • Nanomachines to Control Tissue Healing
  • Eliminating Viruses
  • Correcting Chemistry
  • New Organs and Limbs
  • Fundamental Nanotechnology Research
  • U.S.
  • Europe
  • Japan
  • Risk Factors

Chapter 4 Impact of Covid-19 Pandemic
  • Introduction
  • Outbreak
  • Impact of Covid-19 on Nanomedicine

Chapter 5 Markets for Nanomedicine
  • Market Drivers
  • Market Estimates and Forecasts
  • Global Nanomedicine Market
  • Main Product Categories
  • Market Analysis by Clinical Application

Chapter 6 Global Nanomedicine Market Breakdown by Region
  • Introduction
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • Rest of the World (Row)

Chapter 7 Competitive Landscape
  • Global Company Share Analysis
  • Mergers and Acquisitions
  • Agreements, Collaborations, Product Launches and Partnerships

Chapter 8 Company Profiles
  • Abbott
  • Abraxis Bioscience (Celgene {Bristol Myers Squibb})
  • Aphios Corp.
  • Bioforce Nanosciences Holdings Inc.
  • C Sixty Inc. (Arrowhead Pharmaceuticals)
  • Elan (Alkermes)
  • Eyepoint Pharmaceuticals Inc. (Formerly Psivida Ltd.)
  • Farfield Scientific (Biolin Scientific Ab)
  • Kleindiek Nanotechnik GmbH
  • Liplasome Pharma Aps
  • Magforce Nanotechnologies
  • Microfluidics Corp.
  • Nanobio Corp. (Bluewillow Biologics)
  • Nanobiotix Sa
  • Nanocarrier Co. Ltd.
  • Nanocopoeia, LLC.
  • Nanologix Inc.
  • Nanomix Inc.
  • Nanospectra Biosciences Inc.
  • Nanostructures Inc.
  • Orthovita Inc. (Stryker Corp.)
  • Pfizer Inc.
  • Sanofi S.A.
  • Starpharma
  • Tecangroup Ltd.
  • Transgenex Nanobiotech Inc.

List of Tables
Summary Table A: Global Market for Nanomedicine, by Type, Through 2026
Summary Table B: Global Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 1: Nanomedicine Timescale
Table 2: Main Nanotechnologies Used in Medicine, with Applications
Table 3: Marketed Liposome Nanopharmaceuticals
Table 4: Nanocrystal Pharmaceuticals
Table 5: Marketed and Developmental Products in Micelle Form
Table 6: Marketed Products with Nano-Enhanced Delivery
Table 7: European Nanocenters
Table 8: Marketed Nanopharmaceuticals
Table 9: Global Nanomedicine Market, by Type, Through 2026
Table 10: Global Nanopharmaceuticals Market, by Therapeutic Area, Through 2026
Table 11: Major Marketed Anticancer Nanopharmaceuticals
Table 12: Major Marketed CNS Nanopharmaceuticals
Table 13: Major Marketed Anti-Infective Nanopharmaceuticals
Table 14: Major Marketed Nanomedicines for Cardiovascular and Inflammatory Diseases
Table 15: Global Market for Nanomedicine, by Region, Through 2026
Table 16: North American Market for Nanomedicine, by Type, Through 2026
Table 17: North American Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 18: European Market for Nanomedicine, by Type, Through 2026
Table 19: European Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 20: Asia-Pacific Market for Nanomedicine, by Type, Through 2026
Table 21: Asia-Pacific Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 22: RoW Market for Nanomedicine, by Type, Through 2026
Table 23: RoW Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 24: Global Nanomedicine Market Ranking, by Company, 2020
List of Figures
Summary Figure A: Global Market for Nanomedicine, by Type, 2019-2026
Summary Figure B: Global Market for Nanopharmaceuticals, by Therapeutic Area, 2019-2026
Figure 1: Global Market Share for Nanomedicine, by Region, 2020
Figure 2: Abbott: Annual Revenue, 2018-2020
Figure 3: Abbott: Revenue Share, by Country, 2020
Figure 4: Abbott: Revenue Share, by Business Segment, 2020
Figure 5: Bristol Myers Squibb: Annual Revenue, 2018-2020
Figure 6: Bristol Myers Squibb: Revenue Share, by Region, 2020
Figure 7: Alkermes: Annual Revenue, 2018-2020
Figure 8: Stryker Corp.: Annual Revenue, 2018-2020
Figure 9: Stryker Corp.: Revenue Share, by Region, 2020
Figure 10: Stryker Corp.: Revenue Share, by Business Segment, 2020

Samples

Loading
LOADING...

Executive Summary

Nano-enabled medical products began emerging on the market over a decade ago, and some have evolved as the best-sellers in their therapeutic categories. The leading areas in which nanomedical products have made an impact are CNS diseases, cancer, cardiovascular disease, and infection control.

Moreover, the availability of technologically advanced products and significant investments in nanotechnology-based research in drug discovery studies and cancer therapeutics will also drive the North American market during the forecast period. The Asia-Pacific region’s high growth rate will be due to the drive to address unmet healthcare needs, high prevalence of cancer, high investments in nanotechnology-based research, and growing R&D funding for cancer drug discovery and personalized medicine opportunities.

Companies Mentioned

  • Abbott
  • Abraxis Bioscience (Celgene {Bristol Myers Squibb})
  • Aphios Corp.
  • Bioforce Nanosciences Holdings Inc.
  • C Sixty Inc. (Arrowhead Pharmaceuticals)
  • Elan (Alkermes)
  • Eyepoint Pharmaceuticals Inc. (Formerly Psivida Ltd.)
  • Farfield Scientific (Biolin Scientific Ab)
  • Kleindiek Nanotechnik GmbH
  • Liplasome Pharma Aps
  • Magforce Nanotechnologies
  • Microfluidics Corp.
  • Nanobio Corp. (Bluewillow Biologics)
  • Nanobiotix Sa
  • Nanocarrier Co. Ltd.
  • Nanocopoeia, LLC.
  • Nanologix Inc.
  • Nanomix Inc.
  • Nanospectra Biosciences Inc.
  • Nanostructures Inc.
  • Orthovita Inc. (Stryker Corp.)
  • Pfizer Inc.
  • Sanofi S.A.
  • Starpharma
  • Tecangroup Ltd.
  • Transgenex Nanobiotech Inc.